Khairy: Covid-19 Vaccine Development Funding Given to UM and UPM

In reply to Opposition leader Datuk Seri Anwar Ibrahim’s queries, Khairy said funding has been given to researchers from Universiti Malaya and Universiti Putra Malaysia.

“I am pleased to inform that Mosti has funded the research and development of local vaccines for Covid-19 through the Mosti Combating Covid-19 Fund (MCCOF) to two groups of researchers from Universiti Malaya and Universiti Putra Malaysia.

“However, at the same time, we acknowledge that Malaysia does not now have a complete vaccine manufacturing facility.

“As such, in the negotiations with a few companies for Covid-19 vaccine procurement, the government has incorporated a ‘value-added’ element which enables Malaysia to build up its vaccine development capacity in the future, ” he said in a press statement on Tuesday (March 16).

Earlier, Anwar questioned how soon Malaysia can expect to see their own vaccine-producing facilities, especially as the government previously said the vaccine producers will be required to share their knowledge if they are to sign procurement deals with Malaysia.

Khairy, who is also the coordinating minister of the National Covid-19 Immunisation Programme, also addressed Anwar’s queries about the lack of transparency in Covid-19 procurement agreements.

“The government is still bound by the non-disclosure agreement between the vaccine producers.

“In any case, Health Minister Datuk Seri Dr Adham Baba, Health director-general Tan Sri Dr Noor Hisham Abdullah and myself had on Jan 5 presented the information and details of the matter to the Public Accounts Committee (PAC).

“The PAC, through a statement by its chairman, who is also the Ipoh Timor MP from DAP, has stated that it was satisfied with the presentation and the procurement process of the Covid-19 vaccine.

“There were also PKR representatives in the PAC, ” he said.

Source: https://www.thestar.com.my/news/nation/2021/03/16/khairy-covid-19-vaccine-development-funding-given-to-um-and-upm

Add a Comment

Your email address will not be published.